Proteome-wide alterations in an industrial clavulanic acid producing strain of Streptomyces clavuligerus  by Ünsaldı, Eser et al.
lable at ScienceDirect
Synthetic and Systems Biotechnology xxx (2016) 1e10Contents lists avaiSynthetic and Systems Biotechnology
journal homepage: http: / /www.keaipubl ishing.com/en/ journals /synthet ic-
and-systems-biotechnology/Proteome-wide alterations in an industrial clavulanic acid producing
strain of Streptomyces clavuligerus
Eser Ünsaldı a, Aslıhan Kurt-Kızıldogan a, b, Birgit Voigt c, D€orte Becher c,
Gülay €Ozcengiz a, *
a Department of Biological Sciences, Middle East Technical University, 06800, Ankara, Turkey
b Department of Agricultural Biotechnology, Ondokuz Mayıs University, 55139, Samsun, Turkey
c Institute of Microbiology, Ernst-Moritz-Arndt-University of Greifswald, D-17487, Greifswald, Germanya r t i c l e i n f o
Article history:
Received 3 August 2016
Received in revised form
17 October 2016
Accepted 23 October 2016
“With our special gratitude to Arny for al-
ways being there with his endless pursuit of
scientiﬁc research and support to his Army”
Keywords:
Clavulanic acid
Streptomyces clavuligerus
Industrial strain
Proteomics
2DE
MALDI-TOF/MS* Corresponding author.
E-mail address: ozcengiz@metu.edu.tr (G. €Ozcengi
Peer review under responsibility of KeAi Commu
http://dx.doi.org/10.1016/j.synbio.2016.10.003
2405-805X/© 2016 The Authors. Production and hosti
(http://creativecommons.org/licenses/by-nc-nd/4.0/).
Please cite this article in press as: Ünsaldı E,
clavuligerus, Synthetic and Systems Biotechna b s t r a c t
The usefulness of genetic/metabolic engineering for further improvement of industrial strains is subject
of discussion because of the general lack of knowledge on genetic alterations introduced by iterative
cycles of random mutagenesis in such strains. An industrial clavulanic acid (CA)-overproducer Strepto-
myces clavuligerus DEPA was assessed to understand proteome-wide changes that have occurred in a
local industrial CA overproducer developed through succesive mutagenesis programs. The proteins that
could be identiﬁed corresponded to 33 distinct ORFs for underrepresented ones and 60 ORFs for over-
represented ones. Three CA biosynthetic enzymes were overrepresented in S. clavuligerus DEPA; car-
boxyethylarginine synthase (Ceas2), clavaldehyde dehydrogenase (Car) and carboxyethyl-arginine beta-
lactam-synthase (Bls2) whereas the enzymes of two other secondary metabolites were underrepre-
sented along with two important global regulators [two-component system (TCS) response regulator
(SCLAV_2102) and TetR-family transcriptional regulator (SCLAV_3146)] that might be related with CA
production and/or differentiation. g-butyrolactone biosynthetic protein AvaA2 was 2.6 fold underrep-
resented in S. clavuligerus DEPA. The levels of two glycolytic enzymes, 2,3-bisphosphoglycerate-depen-
dent phosphoglycerate mutase and phosophoglycerate kinase were found decreased while those of
dihydrolipoyl dehydrogenase (E3) and isocitrate dehydrogenase, with two isoforms were found as
signiﬁcantly increased. A decrease of amino acid metabolism, methionine biosynthesis in particular, as
well as S-adenosylmethionine synthetase appeared as one of the prominent mechanisms of success of
S. clavuligerus DEPA strain as a proliﬁc producer of CA. The levels of two enzymes of shikimate pathway
that leads to the production of aromatic amino acids and aromatic secondary metabolites were also
underrepresented. Some of the overrepresented stress proteins in S. clavuligerus DEPA included poly-
nucleotide phosphorylase/polyadenylase (PNPase), ATP-dependent DNA helicase, two isoforms of an
anti-sigma factor and thioredoxin reductase. Downregulation of important proteins of cell wall synthesis
and division was recorded and a protein with b-lactamase domain (SCLAV_p1007) appeared in 12 iso-
forms, 5 of which were drastically overrepresented in DEPA strain. These results described herein provide
useful information for rational engineering to improve CA production in Streptomyces clavuligerus.
© 2016 The Authors. Production and hosting by Elsevier B.V. on behalf of KeAi Communications Co. This is
an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Clavulanic acid (CA) is a bicyclic compound with a b-lactam and
an oxazolidine ring [1]. It has a weak antibacterial activity but is a
very powerful class of b-lactamase inhibitor naturally produced by
Streptomyces clavuligerus. CA is active against a wide spectrum ofz).
nications Co., Ltd.
ng by Elsevier B.V. on behalf of KeA
et al., Proteome-wide alterat
ology (2016), http://dx.doi.openicillin- and cephalosporin-resistant bacteria exerting its func-
tion by irreversibly binding to serine hydroxyl group in active sites
of b-lactamases. Due to synergistic effect, it is co-formulated with
conventional b-lactam antibiotics and prescribed clinically in
combination with amoxycillin as Augmentin™ and with ticarcillin
as Timentin™ [2]. S. clavuligerus fermentations are used for CA
production in bioindustry as its large scale chemical synthesis is
still not feasible [3].
Draft genome sequence of S. clavuligerus has revealed loci ofi Communications Co. This is an open access article under the CC BY-NC-ND license
ions in an industrial clavulanic acid producing strain of Streptomyces
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clavams (Fig. 1). Cephamycin and CA supercluster and clavam gene
cluster are located on the chromosome, whereas paralog gene
cluster lies on a large linear plasmid, pSCL4. The megaplasmid
pSCL4 of S. clavuligerus is packed with at least 25 secondary
metabolite biosynthetic gene clusters that are identical or resem-
bling to those from other Streptomyces spp, supporting the hy-
pothesis that many secondary metabolism biosynthetic gene
clusters in bacteria are acquired by horizontal gene transfer.
Together with the clusters on the chromosome, the total number of
putative secondary metabolite gene clusters reaches to 48. These
include 10 putative nonribosomal peptide synthetase (NRPS) gene
clusters, eight putative PKS gene clusters, and six gene clusters
putatively encoding NRPSs and PKSs or NRPS-PKS hybrids as well as
12 clusters putatively encoding one or more terpene synthases or
cyclases [4].
Although whole characterization of ORFs in CA gene cluster has
not yet been completed, essential biosynthetic genes were clearly
identiﬁed [5e8]. Pathway leading to the biosynthesis of CA in
S. clavuligerus is shown in Fig. 2. Among biosynthetic genes of CA
cluster, cas2 encodes for a rate-limiting enzyme, clavaminic acid
synthase [9]. CA biosynthesis is controlled by pleiotropic regulators
like BldG and BldA [10] and AdpA [11], and pathway-speciﬁc reg-
ulators (cluster situated regulators) CcaR, a transcriptional activator
encoded by ccaR located in cephamycin C gene cluster and CA
pathway-speciﬁc ClaR activator encoded by claR [12,13]. The roles
of CcaR stimulating both cephamycin C and CA clusters and ClaR as
the positive regulator of CA biosynthetic cluster have been well
documented. In ccaR-deleted mutant, both “early” and “late” genes
of CA biosynthesis pathway were downregulated while claR dele-
tion led to low level of expression in “late” genes in CA cluster when
compared to the parental strain [12e15]. Deletion of bldA led to
underrepresentation of Cas2, OppA1 and GcaS proteins while
deletion of bldG additionally resulted in the low formation of Bls2
[10]. Stringent response protein RelA positively affects CcaR
expression indirectly while another response regulator, Orf-23
exerts its direct effect on CA biosynthesis by positively regulating
ClaR expression [8]. g-butyrolactones are also involved in regula-
tion of CA biosynthesis in S. clavuligerus at different levels. Although
no butyrolactone of A-factor type of S. griseus has been reported in
S. clavuligerus [16,17], Brp is a butyrolactone receptor protein in this
organism which is homologous to S. griseus ArpA and involved in
negative regulation of antibiotic biosynthesis. It exerts its effect by
binding to ARE boxes found in the ccaR and adpA promoters as wellFig. 1. Three distinct clusters involved in biosynthesis of CA and 5
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has been demonstrated, and brp-deletedmutants overproduced CA
signiﬁcantly. AreB might affect brp expression which is down-
regulated during the ﬁrst 36 h of cultivation and this decrease of
Brp has been reported to result in a higher clavulanic acid pro-
duction [17]. In an areB-deleted mutant, ARE(ccaR)Brp complex can
not be formed, leading to a general increase in CA levels [18] (Fig. 3).
Strain improvement strategies are commonly employed to
achieve high-titers of industrial metabolites, including b-lactams
[19,20]. For instance, an industrial S. clavuligerus strain with a 100-
fold higher CA production capacity in comparison to its wild type
counterpart was generated by random mutagenesis and screening
[21]. Indeed, the integration of the tools of “classical” and “modern”
approaches enables the researchers to stack multiple complex
phenotypes [22]. For CA overproduction, the genetic and metabolic
engineering approaches involving altering expression levels of
biosynthetic or regulatory genes, increasing precursor ﬂow into the
pathway or eliminating competing reactions by oriented modiﬁ-
cations have been applied mostly to the laboratory strains of
S. clavuligerus, as summarized in Table S1 [11e13,23e29]. Because
standard strains are able to produce only limited amounts of sec-
ondary metabolites, application of knowledge-based gene manip-
ulations in industrial strains derived from randommutagenesis and
selection might provide more productive strains [16,30]. Despite
the fact that classical methodology is slow and laborious, its long
history of success still fascinates researchers, especially with the
availability of high throughput screening and analytical technolo-
gies today in the post-“omics” era [22]. Regarding “omics” of b-
lactam overproducers, a comparison among the cytosolic pro-
teomes of the wild-type Penicillium chrysogenum NRRL 1951, Wis-
consin 54- 1255 (an improved, moderate penicillin producer), and
AS-P-78 (a penicillin high producer) strains [31] has been re-
ported. Also genome-wide gene expression in an industrial clav-
ulanic acid overproducing Streptomyces clavuligerus [21] was
already described. S. clavuligerus DEPA used for CA manufacturing
process in Turkey produces at least 100-fold more CA relative to the
wild type S. clavuligerus. In the present study, with the aim of
providing insight into the modiﬁcations that this strain has un-
dergone during the iterative cycles of mutagenesis program,
S. clavuligerus NRRL3585 and DEPA strains were analyzed by
comparative proteomics based on 2DE followed by protein identi-
ﬁcation via MALDI-TOF/MS.S clavams in S. clavuligerus (adapted from Hamed et al. [85]).
ions in an industrial clavulanic acid producing strain of Streptomyces
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Fig. 2. Pathway leading to the biosynthesis of CA in S. clavuligerus. Clavaminic acid represents the branch point intermediate that separates CA biosynthesis from that of 5S clavams.
Cofactors as well as co-substrates are also shown. Dashed arrow indicates a yet uncharacterized step in the pathway (adapted from Arulanantham et al. [86]; Hamed et al. [85] and
€Ozcengiz and Demain [20]).
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2.1. Bacterial strains and culture conditions
S. clavuligerus strains NRRL3585 [32] and DEPA (DEPA Pharma-
ceuticals Co., _Izmit, Turkey) were used as the wild type and in-
dustrial CA overproducer, respectively. The strains were grown at
28 C at 220 rpm in bafﬂed ﬂasks in Tryptic Soya Broth (TSB) for
stock preparation.
For the preparation of seed cultures, 200e600 mL of
S. clavuligerus stock cultures were added into 50 mL of TSB medium
and incubated for 24e48 h at 28 C at 220 rpm. Optical density of
seed cultures was measured according to the procedure by
Malmberg et al. [33]. 0.5 mL of sample from seed culturewas mixed
with 3 mL of distilled water and 0.5 mL of 2.5 M HCl and then the
mixture was homogenized via sonication (Ultrasonic Processor,
Cole Parmer) for 3  30 s at 50% amplitude. When the OD600 of
homogenized mixture reached to 0.7e0.8, 25 mL of seed culture
was centrifuged at 4000g for 10 min at 4 C and the pellet was
washed with freshmedium. The cells were re-suspended in 100mLPlease cite this article in press as: Ünsaldı E, et al., Proteome-wide alterat
clavuligerus, Synthetic and Systems Biotechnology (2016), http://dx.doi.oof Starch-Asparagine (SA) medium, a deﬁnedmedium favouring CA
production [34] and the cultures were grown at 28 C at 220 rpm
for 48 h for proteome analyses.2.2. Protein extraction
Protein extraction was slightly modiﬁed from Faurobert et al.
[35]. Cell cultures harvested after 48 h were centrifuged at 6000g
for 15 min and washed with fresh medium once. Immediately after
that, the pellets were frozen in liquid nitrogen and stored at80 C
until use. Frozen cultures were ground in liquid nitrogen in mortar
and 1 g of ground cell culture was suspended in 3 mL of protein
extraction buffer [500 mM Tris-HCl, 50 mM EDTA, 700 mM sucrose,
100mMKCl, pH 8.0, freshly added 2% b-mercaptoethanol and 1mM
phenylmethylsulfonyl ﬂuoride (PMSF)] in a 15 mL Falcon tube,
vortexed gently and then incubated by shaking for 10min on ice. An
equal volume of Tris-buffered phenol (pH 8.0, Sigma) was added,
the solution was mixed gently and incubated by shaking at RT for
10 min. After centrifugation at 3400g for 15e20 min, the phenolic
phase was recovered and transferred to another tube. The phenolicions in an industrial clavulanic acid producing strain of Streptomyces
rg/10.1016/j.synbio.2016.10.003
Fig. 3. Regulation of CA biosynthesis in S. clavuligerus NRRL3585 as based on previous reports cited in the text. Lines with pointed arrows show positive regulation while lines with
perpendicular ends indicate suppression. Arrows with dashed lines point to the speciﬁc genes, the expression of which are dependent on BldA and BldG. *: ﬁrst 36 h of cultivation,
**: dependent only on BldG, SMA: Small Molecule Autoregulator yet unidentiﬁed.
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buffer and the mixture was shaken for 3 min at RT and vortexed.
After centrifugation for 15e20 min at 3400g, the phenolic phase
was recovered. 4 volume of precipitation solution (0.1 M ammo-
nium acetate in cold acetone) was added to it, the solution was
mixed and the proteins were precipitated overnight at 20 C. This
was followed by centrifugation for 10 min at 3400g, washing three
times with cold precipitation solution then with cold acetone.
During each washing step, samples were incubated at 20 C for
30 min and then centrifuged for 10e15 min at 3400g. Pellet was
dried either overnight at 20 C or under Speed-Vac.2.3. Determination of protein concentration
Protein pellets were dissolved in rehydration buffer [36] and
protein concentration was determined by using the modiﬁed
Bradford assay as in Ramagli and Rodríguez [37] using bovine
serum albumin as standard.2.4. 2DE, image and data analyses
After samples were dissolved in rehydration buffer, linear IPG
strips (18 cm, pH 4e7, BioRad) were rehydrated for 12e16 h by
applying 400 ml of rehydration buffer containing 350 mg protein
sample on BioRad PROTEAN IEF Cell. Isoelectric focusing (IEF) for
the ﬁrst dimension was performed with Immobilised pH Gradient
(IPG) System “Ettan IPGphor3” (Amersham Biosciences, GE
Healthcare). The voltage applied was as the following: 250 V
(Gradient) for 1.5 h, 500 V (Gradient) for 1.5 h, 1000 V (Gradient) for
3 h, 5000 V (Gradient) for 4 h, 8000 V (Gradient) for 12 h, 500 V
(Steep) for 2 h. After IEF, gels were either kept at 20 C or directly
equilibrated at RT ﬁrst with 4 mL of Equilibration Buffer Solution I
(50 mM Tris-Cl pH 6.8, 6 M urea, 30% (v/v) glycerol, 1% SDS, 2% DTT)
and secondly with 4 mL of Equilibration Buffer Solution II (50 mM
Tris-Cl pH 6.8, 6 M urea, 30% (v/v) glycerol, 1% SDS, 2.5% iodoace-
tamide, 3.5 mM bromophenol blue) The isolated proteins were
separated in 12% acrylamide/bis-acrylamide gels with a 4% stackingPlease cite this article in press as: Ünsaldı E, et al., Proteome-wide alterat
clavuligerus, Synthetic and Systems Biotechnology (2016), http://dx.doi.ogel using Bio-Rad Cell system (Bio-Rad, USA), applying approxi-
mately 27 mA per gel. To visualize the separated proteins, each gel
was stained with colloidal Coomassie Blue G-250 [38]. Stained gels
were digitized by using a scanner (Epson Perfection V750). The 2D
image analysis software Delta2D version 3.4 (Decodon, Germany)
was used for spot pattern analyses. Two biological replicates were
used for each strain. Gels in each group (S. clavuligerus NRRL3585
and S. clavuligerus DEPA) were used to generate a fused (master) gel
image which contained all the spots coming from each gel. Spot
volume representing the spot abundance for each spot in the
master images was used as a measure for the quantitation of
expression differences between the spots on the S. clavuligerus
NRRL3585 and DEPA gels. Spot abundance on a gel was expressed
as volume percentage (%V). The volume of all spots on an image
amounts to 100% and hence the relative ratio of a spot to all spots
on the gel can be described as its own %V. Image analysis software
automatically normalizes %V of spots in each gel. By using the %V
ratios for each spot on S. clavuligerus NRRL3585 and S. clavuligerus
DEPA master gels, spot intensity showing 2.5-fold change in
S. clavuligerus DEPA strain with respect to S. clavuligerus NRRL3585
was selected for identiﬁcation by MALDI-TOF/MS analysis. After
this, the statistical analyses for 2DE experiments were performed
by using Delta2D 4.3 statistical tools to determine the statistical
signiﬁcance of the spots that showed 2.5-fold difference. For
comparison of S. clavuligerus NRRL3585 and DEPA strains, paired t-
test was used with Welch approximation and a value was equal to
0.05.2.5. MALDI-TOF/MS analyses
Protein spots selected for identiﬁcation were excised from 2DE
gels with Proteome Works Spot Cutter System (Bio-Rad). In-gel
trypsin digestion and extraction of the peptides were conducted
by Ettan Spot Handling Workstation (GE Healthcare) as described
in manufacturer's protocol and by Kierul et al. [39]. To summarize
the process, gels pieces were washed twice with 50 mM of
NH4HCO3 containing 50% CH3CN for 30 min and then washed onceions in an industrial clavulanic acid producing strain of Streptomyces
rg/10.1016/j.synbio.2016.10.003
Fig. 4. Cytosolic proteome of S. clavuligerus DEPA and protein spots that showed more
than 2.5 fold increase in intensity compared to those in S. clavuligerus NRLL3585 (pI
4e7, from left to right).
Fig. 5. Cytosolic proteome of S. clavuligerus DEPA and protein spots that showed more
than 2.5 fold decrease in intensity compared to those in S. clavuligerus NRLL3585 (pI
4e7, from left to right).
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for 17 min. With the addition of 10 ml of trypsin solution (20 ng/ml
trypsin) (Promega, Madison, WI, USA), gel pieces were incubated at
37 C for 120 min. Extraction of the peptides was performed by
covering themwith 0.1% triﬂuoroacetic acid in 50% CH3CN and then
incubating at 40 C for 30 min. Supernatants were transferred into
another microtiter plate and extraction process was repeated. Su-
pernatants were completely dried at 40 C for 220 min. The pep-
tides were dissolved in 2.0 ml matrix solution consisting of a-cyano-
4-hydroxy cinnamic acid in 50% CH3CN/0.5% triﬂuoroacetic acid.
0.7 ml of this mixture was spotted on the MALDI target. 4800
MALDI- TOF/TOF Proteomics Analyser (Applied Biosystems) was
used for the peptide mass determination. Spectra were recorded in
a mass range from 900 to 3700 Da with a focus mass of 2000 Da.
4000 Series Explorer software was used for spectrum calibration
and analysis. TOF/TOF measurements were performed for the two
highest peaks in a spectrum when possible.
2.6. Protein identiﬁcation
For the database search, the Mascot search engine version 2.1
(Matrix Science) was used with S. clavuligerus sequence database
retrieved from UniProt (http://www.uniprot.org/). The peak lists of
each protein spot (peptide mass ﬁngerprint and MS/MS data) ob-
tained from MALDI TOF/MS measurement were analyzed with the
aid of “Peptide Mass Fingerprint” and “MS/MS Ion Search” engines
of MASCOT software (Matrix Science Inc., Boston, MA, USA) against
the data retrieved from UniProt for S. clavuligerus. The results
showing a probability score higher than 53 were assumed to be
meaningful and used for protein identiﬁcation.
2.7. Databases for protein categorization, function and associations
Functional categories of the proteins were mostly determined
by using COG database provided by NCBI (ftp://ftp.ncbi.nih.gov/
pub/COG/COG2014/static/lists/listStrbin.html). Cellular localiza-
tions of the proteins were determined using PSORTb version 3.0.2
(http://www.psort.org/psortb/), Gpos-mPloc (http://www.csbio.
sjtu.edu.cn/bioinf/Gpos-multi/#) and ngLoc (http://genome.unmc.
edu/ngLOC/index.html) databases. Theoretical pI and Mw values
of the proteins were calculated by using Expasy pI/Mw tool [40].
Protein pathways and associations were predicted using STRING
10.0 (http://string-db.org/) which is a global source of genes from
which protein associations can be inferred and predicted [41].
3. Results and discussion
The protein spots on 2DE gels of S. clavuligerus DEPA with at
least 2.5 fold up- and down-regulation are shown in Figs. 4 and 5,
respectively. Dual channel 2DE imaging (pI 4e7) of S. clavuligerus
strains NRRL3585 and DEPA provides a picture of differential
expression (Fig. S1). The proteins that could be identiﬁed corre-
sponded to 33 distinct ORFs for overrepresented ones and 60 ORFs
for underrepresented ones (supplementary Table S2 and Table S3,
respectively). Six of the overrepresented and 10 of the underrep-
resented proteins appeared in two or more spots, differing in either
their charge and/or mass, suggesting posttranslational modiﬁca-
tions like phosphorylation, glycosylation and more delicate cova-
lent modiﬁcations as well as intended proteolytic cleavage. On the
other hand, the presence of multiple spots of the same protein on 2-
D gels resulting from unintended protein degradation can not be
ruled out, either.
The identiﬁed proteins were then functionally classiﬁed with
respect to their biological functions. The relative functional distri-
butions of up- and down-regulated proteins are presented inPlease cite this article in press as: Ünsaldı E, et al., Proteome-wide alterat
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(34%), “hypothetical/unknown” (18%) and “secondary metabolism”
(9%) proteins constituted about 60% of the identiﬁed over-
represented ones while “amino acid metabolism” (20%), “hypo-
thetical/unknown” (18%) and “secondary metabolism” (9%) were
the most prominent classes regarding the underrepresented
proteins.3.1. CA biosynthesis
Three CA biosynthetic enzymes were overrepresented in
S. clavuligerus DEPA; carboxyethylarginine synthase (Ceas2),ions in an industrial clavulanic acid producing strain of Streptomyces
rg/10.1016/j.synbio.2016.10.003
Fig. 6. Pie charts depicting the functional classiﬁcation of overrepresented(A) and underrepresented(B) proteins in S. clavuligerus DEPA strain.
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lactam-synthase (Bls2) with 11, 8.2 and 20.6 fold increase, respec-
tively. Both Ceas2 and Bls2 are early biosynthetic enzymes that are
required for both the CA and clavam biosynthesis. On the other
hand, Car which catalyzes the last step of CA production is not
involved in clavam biosynthesis. Interestingly, proclavaminate
amidinohydrolase (Pah2) which is involved in early steps of CA
biosynthesis as well as in clavam biosynthesis was 4.8 fold down-
regulated. It is known that Pah is encoded by two paralogous genes:
pah1 and pah2. pah2 and pah1 mutants do not show considerable
differences in the levels of CA compared to the parental strain [42].
It can then be speculated that the industrial strain might prefer
Pah1 over Pah2 for CA production. Alternatively Pah may not be
crucial, or yet unknown proteins might perform the same role in
the pathway as Pah1/Pah2. As pathway speciﬁc activators, both
CcaR and ClaR were expected to appear in the overrepresented
protein list of S. clavuligerus DEPA; however, our proteome study
did not identify these as differentially expressed proteins.3.2. Other secondary metabolites
Underrepresented proteins of secondary metabolism other than
CA biosynthesis included deacetoxycephalosporin C hydroxylase
(7.6 fold) involved in cephamycin biosynthesis, MoeA5 protein (4.7
fold) involved in moenomycin biosynthesis, and a putative ami-
noglycoside 2-N-acetyltransferase Aac2 (22.7 fold). Aminoglycoside
2-N-acetyltransferases of AAC(20) family are generally engaged in
the acetylation of aminoglycosides dibekacin, gentamicin, kana-
mycin, netilmicin, and tobramycin [43,44]. As the genes for self-
resistance are generally known to be located in antibiotic biosyn-
thetic gene clusters, the presence of a strongly downregulated
aminoglycoside 2-N-acetyltransferase could be indicative of sup-
pression of aminoglycoside biosynthesis in CA overproducer, yet no
clusters encoding enzymes related to aminoglycoside biosynthesis
were reported in the genome of S. clavuligerus [4]. It would be quite
reasonable to postulate that the elimination of the production of
other secondary metabolites is one of the mechanisms that
S. clavuligerus DEPA exploits to increase CA biosynthesis, but the
levels of these metabolites remain to be determined and compared
with those in wild type strain.3.3. Regulators of secondary metabolism
g-butyrolactones are small extracellular autoregulatorsPlease cite this article in press as: Ünsaldı E, et al., Proteome-wide alterat
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crucial roles in the secondary metabolism and morphological dif-
ferentiation [45,46]. (SCLAV_0471) was 2.6 fold underrepresented
in S. clavuligerus DEPA. avaA2 codes for an Afs-like autoregulator
synthase in S. clavuligerus. It has 31% amino acid identity to AfsA
which is responsible for synthesis of classical autoregulatory g-
butyrolactone (A-factor) in S. griseus [47]. When A-factor is absent
in cells, A-factor receptor protein, ArpA binds to adpA promoter and
represses its transcription. However, when A-factor level exceeds a
threshold value, it binds to ArpA and causes its dissociation from
adpA promoter. As a result, AdpA can function as transcriptional
activator of antibiotic biosynthesis [48]. No butyrolactones of A-
factor type of S. griseus have been described in S. clavuligerus yet,
and their role, or the role of AvaA2, remains to be studied.
From the 72 distinct putative TCS located in S. clavuligerus
genome, only SCLAV_2102 was identiﬁed as 4.5 fold down-
represented in the DEPA strain, it might negatively regulate the
formation of CA or CA precursors; however, the TCS orf22/23
described as positive regulator of CA formation [49] was not
affected in the industrial strain. TCSs, as AbrA1/A2 or AbrC1/C2/C3
have been described to control antibiotic biosynthesis in
S. coelicolor [50] and TCS inactivation has been shown to stimulate
the biosynthesis of gougerotin in S. graminearus [51], avermectin in
S. avermitilis [52] and erythromycin in Saccharopolyspora erythraea
[53], which supports a role for SCLAV_2102 in CA regulation.3.4. Carbohydrate metabolism
In a previous study in which genome-wide gene expression
changes in an industrial clavulanic acid overproduction strain of
S. clavuligerus were investigated [21], the levels of glycolytic en-
zymes (2,3-bisphosphoglycerate-dependent phosphoglycerate
mutase and phosophoglycerate kinase) in between glyceraldehyde-
3-phosphate and phosphoenolpyruvate were found unchanged in
their industrial strain. However, as found in our proteomics study,
both enzymes were downregulated by 4.7 and 4.9 folds, respec-
tively. Also found in our study was upregulation of aconitate
hydratase by 4.6 fold in S. clavuligerus DEPA strain. This ﬁnding was
not consistent with that of the microarray analysis [21]. In that
study, the levels of two consecutive enzymes of TCA cycle, namely
citrate synthase and aconitase, decreased over two fold in the in-
dustrial mutant by a possible reduction in carbon ﬂux from G3P in
this direction since the ﬂux is partly redirected to clavulanic acid
biosynthesis, as explained by the authors. On the other hand, thereions in an industrial clavulanic acid producing strain of Streptomyces
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transcripts of pyruvate kinase, citrate synthase and cis-aconitate,
and thus a considerable pool of acetyl-CoA is maintained, e.g. for
the biosynthesis of ornithine from glutamate. We found dihy-
drolipoyl dehydrogenase (E3), one of the three components of the
bacterial pyruvate dehydrogenase multienzyme complex, and iso-
citrate dehydrogenase, with two isoforms, as signiﬁcantly over-
represented proteins; however, the former was over two fold
underrepresented and the level of the latter was unchanged in
microarrays [21]. Notably, an additional protein spot possibly rep-
resenting a different isoform of isocitrate dehydrogenase was 3 fold
downregulated. Since these enzymes are related to the formation of
metabolites which are used for a large variety of biosynthetic
processes and include a-ketoglutarate family of amino acids with
arginine as a precursor of CA, their elevated levels in a CA over-
producer were as expected. Indeed, the differences between tran-
scriptome and proteome data described herein are not all that
surprising and systems-level analysis of metabolic pathways by the
integration of genome, transcriptome, proteome, metabolome and
ﬂuxome data with in silico modelling and simulation will provide
in-depth understanding of the whole cellular physiology in relation
to CA production.
3.5. Amino acid metabolism
Another prominent mechanism of success of S. clavuligerus
DEPA strain as a proliﬁc producer of CA was demonstrated as
downregulation of amino acid metabolism, methionine biosyn-
thesis in particular. In this way, more aspartate would be directed
towards L-arginine (CA precursor) biosynthesis instead of being
also shared by methionine biosynthesis route. Cystathionine
gamma-synthase (SCLAV_5668), as represented by 5 different spots
on the S. clavuligerus DEPA gel forming a pearl-like pattern sug-
gested an extensive posttranslational modiﬁcation and these spots
were at 3.5e83 fold decreased levels andmost probably, along with
other downregulated enzymes of methionine biosynthesis, served
for lowering the metabolic ﬂux to methionine. O-acetylhomoserine
aminocarboxypropyltransferases which are historically known as
O-acetylhomoserine thiolases (MetY) can accept methanethiol as
the attacking nucleophile, resulting in the direct synthesis of
methionine instead of a homocysteine intermediate [54]. Over 6
fold underrepresented levels of O-acetylhomoserine amino-
carboxypropyltransferase (SCLAV_5559) identiﬁed in this study
also provided evidence that streptomycetes utilize this single step
conversion in addition to two step trans-sulfuration. The S-
methylation of homocysteine is the ﬁnal step in methionine
biosynthesis. Either one of two non-homologous enzymes, namely
cobalamin-dependent methionine synthase (MetH); or cobalamin-
independent methionine synthase, also known as 5-
methyltetrahydropteroyltriglutamate homocysteine methyl-
transferase (MetE) is theoretically employed for this reaction in
E. coli. However since this organism has lost cobalamin biosynthetic
pathway, it uses MetH only in the presence of exogenous cobal-
amin; moreover, it represses MetE in such conditions [54]. MetE
catalyses direct transfer of a methyl group from the triglutamate
derivative of 5- methyl-tetrahydrofolate to homocysteine [55]. In
our study, MetE was represented by two isoforms, at up to 3 fold
downregulated levels. Another cobalamin-independent enzyme
also known as methionine synthase II (SCLAV_p1324) was also
downregulated by 4 fold. While the primary function of S-adeno-
sylmethionine synthetase (SAM; MetK) is to donate methyl groups
to diverse metabolites coming from primary or secondary meta-
bolism as well as proteins, nucleic acids and polysaccharides [56], it
has also been shown to affect the secondary metabolism andPlease cite this article in press as: Ünsaldı E, et al., Proteome-wide alterat
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tion of multicopymetK genes as well as exogenous addition of SAM
to S. coelicolor cells increased the production of actinorhodin [58].
Increased levels of SAMwere also shown to increase the production
of bicozamycin in Streptomyces griseoﬂavus, pristinamycin in
Streptomyces pristinaespiralis, granaticin in Streptomyces violaceor-
uber [56]. In addition, SAM binds mRNA molecules to regulate the
transcription in B. subtilis [57]. Kim et al. [59] showed that SAM
itself can act on a transcriptional activator to increase the antibiotic
levels in Streptomyces lividans. A decrease in the biosynthesis of
secondary metabolites apart from CA in our industrial strain would
be quite favorable for CA overproduction. Thus, it is very likely that
a 2.6 fold reduction in the level of SAM synthetase together with a
strongly downregulated levels of methionine biosynthesis
contributed to the increased CA levels in S. clavuligerus DEPA.
Two other underrepresented enzymes of amino acid meta-
bolism were 3-dehydroquinate synthase (AroB) and 3-
phosphoshikimate 1-carboxyvinyltransferase (also known as 5-
enolpyruvylshikimate-3-phosphate synthase; AroA) of shikimate
pathway leading to aromatic amino acids and other aromatics.
Streptomyces uses this pathway also to produce precursors for some
secondary metabolites such as aromatic polyketide antibiotics. For
instance, cyclohexanecarboxylic acid, a derivative of shikimic acid
is used for the biosynthesis of ansatrienin (mycotrienin) in Strep-
tomyces collinus [60], and another derivative of shikimic acid,
dihydroxycyclohexanecarboxylic acid, is used for ascomycin
(immunomycin; FK520) production in Streptomyces hygroscopicus
var ascomyceticus [61].
3.6. Lipid metabolism
Two underrepresented proteins in lipid metabolism, 3-oxoacyl-
[acyl-carrier-protein] reductase (SCLAV_1028) and enoyl-[acyl-
carrier-protein] reductase (FabI), are the components of FAS II
fatty acid biosynthetic system found in bacteria [62]. The questions
of whether or not (i) Fas II and PKS pathways share protein com-
ponents, and (ii) Fas II system plays an indirect role in providing
building blocks for synthesis of PKs have been tried to be addressed
almost exclusively in Streptomyces spp. due to the remarkable di-
versity of type II polyketides in these bacteria as well as the analogy
between their PKSs and Fas II enzymes composed of discrete
monofunctional proteins [63]. There still exist some contradictory
ﬁndings. On the other hand, the possibility that downregulation of
these two Fas II enzymes might limit PK synthesis either directly or
indirectly in industrial CA producer cannot be ruled out.
3.7. Stress response
Tolerance to environmental stress is one of the desirable traits of
industrial strains. The overrepresented relevant proteins included
polynucleotide phosphorylase/polyadenylase (PNPase), ATP-
dependent DNA helicase (SCLAV_4693), two isoforms of an anti-
sigma factor (SCLAV_2541) and thioredoxin reductase
(SCLAV_5275) with 11, 1344, 7.3, 3.3 and 3.3 fold upregulation,
respectively. Being a component of RNA degradosome [64], PNPase
seems to be a critical component of the cell under oxidative stress
conditions. When E. coli pnp mutants were subjected to H2O2, the
cells accumulated 8-oxoG in cellular RNA; however, when the cells
were complemented with pnp gene, the amount of oxidized RNAs
were minimized [65]. According to the UniProtKB database, ATP-
dependent DNA helicase is a RecQ type ATP-dependent DNA heli-
case family responsible for genome maintenance [66]. Anti-s fac-
tors bind to the related alternative s factor, thereby preventing
them from initiating the transcription of certain genes until theions in an industrial clavulanic acid producing strain of Streptomyces
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reductase, thioredoxins have quite diverse functionswithin the cell,
including cell division, detoxiﬁcation/oxidative stress response,
energy transduction, protein folding and degradation, transcription
regulation, translation and some unknown functions [68]. COG
database classiﬁes thioredoxin reductase under the functional
category of “Stress-Related, Protein Turnover, Chaperones”. How-
ever, thioredoxin reductase (SCLAV_5275) protein in this study has
been identiﬁed as a thioredoxin oxidoreductase-like dithiol oxi-
dase, namely HlmI, from the dithiolopyrrolone antibiotic hol-
omycin producer S. clavuligerus, which constructs intramolecular
disulﬁde bridge from the acyclic ene-dithiol at a late stage in the
holomycin biosynthetic pathway [69]. Indeed, it was shown much
earlier that mutants of S. clavuligerus with ORF disruptions in
different genes for CA biosynthesis overproduce holomycin [70]. In
accordance with this ﬁnding, Li and Walsh [69] demonstrated that
DORF15 S. clavuligerus produced more holomycin than the wild
type and the level of holomycin produced by DhlmI and DhlmI/
DORF15 strains decreased by 102103 folds in comparison to that of
wild type and the DORF15mutant. Moreover, hlmI deletions inwild
type and DORF15 S. clavuligerus strains rendered both strains more
susceptible toward holomycin. This suggested that holomycin may
also exist in the inactive disulﬁde form and become reduced in the
cellular environment yielding the active form of the antibiotic, HlmI
possibly acting as a protective catalyst against holomycin in the
producer. The transcriptomic analysis of a ccaR- and claR-deleted
mutants further veriﬁed the cross-regulation of CA and holomycin
biosynthetic pathways in that all the holomycin biosynthesis genes
including hlmI were overexpressed in these mutants [14,15]. In
viewof all these ﬁndings, the increase in HlmI level in S. clavuligerus
DEPA seems to be related with its functions other than holomycin
biosynthesis.
A putative uncharacterized protein (SCLAV_0035) and Rhs
element Vgr protein (SCLAV_0043) upregulated 3e4 fold in
S. clavuligerus DEPA strain might provide clue for the existence of a
contact-dependent type 6 secretion (T6SS)-like system in
S. clavuligerus. Indeed, this organism is known to possess three
main types of general protein secretion systems, namely the Sec
pathway, the Esx secretion system (T7SS) and the Tat pathway
[71]. STRING search revealed phage tail region proteins and Vgr
proteins as the functional partners of SCLAV_0035. Rhs elements
are accessory repetitious sequences which are the major source for
chromosomal rearrangements in laboratory cultures. vgr (Val-Gly
dipeptide repetition) is located upstream of the core regions and
found only in RhsE and RhsG elements in E. coli [72]. Although
T6SS has been known to be conﬁned to Proteobacteria and basi-
cally important in pathogenesis, it also functions in resisting
predation, sensing stress, regulating bacteria-bacteria interactions,
in particular helping in competition for a speciﬁc niche in different
bacteria [73,74]. Siderophore-interacting family proteins are con-
tained within the biosynthetic gene clusters for siderophores and
are responsible to reduce iron-siderophore complexes for
releasing iron, hence cellular incorporation [75]. Almost 5 fold
upregulation of SIB (SCLAV_0843) was indicative of an increased
need for siderophore function in the industrial strain especially
when non-classical biological functions of siderophores like non-
iron metal transport, toxic metal sequestration, protection from
oxidative stress and molecular signaling [76] are also considered.
Moreover, siderophores are listed among the small molecules of
primary metabolism or core physiology controlling antibiotic
production although the relevant mechanisms remain to be
elucidated [47]. Another upregulation was recorded in the YceI
family (SCLAV_4479) which are involved in osmotic and acid
stresses [77,78].Please cite this article in press as: Ünsaldı E, et al., Proteome-wide alterat
clavuligerus, Synthetic and Systems Biotechnology (2016), http://dx.doi.o3.8. Others
It is worth noting the signiﬁcant downregulation of cell division
protein FtsZ, teichoic acid (TA) biosynthesis protein, UDP-N-
acetylmuramoyl-tripeptide–D-alanyl-D-alanine ligase and alanine
racemase domain protein in S. clavuligerus DEPA, which might
point to a general slowdown in cell wall synthesis and division
compared to the S. clavuligerus NRRL3585. Interestingly, as many as
83 times decreased levels of TA biosynthetic protein and localiza-
tion of the tagC gene encoding this protein on pSCL4 were observed
while this megaplasmid did not seem to encode any functions
essential to primary metabolism, as reported earlier [4].
One of the most striking difference between the industrial
overproducer and S. clavuligerus DEPA was recorded for pSCL4
encoded protein with a b-lactamase domain (SCLAV_p1007). The
protein appeared in 12 upregulated isoforms, ﬁve of which were
drastically overrepresented in S. clavuligerus DEPA strain. A total of
22 proteins with a predicted b-lactamase domain was detected on
the chromosome or megaplasmid of the organism [4]. Although
S. clavuligerus b-lactamases have not yet been experimentally
characterized, posttranslational modiﬁcations like lysine carbox-
ylation in Class D [79,80] as well as proteolytic modiﬁcation of zinc-
based or metallo b-lactamases in Class B which are not inhibited by
clavulanic acid [81] were reported. Phylogenetically diverse b-lac-
tamases that exist in Streptomyces spp. and their relation with self-
resistance were extensively reviewed very recently [82] with no
speciﬁc information about SCLAV_p1007 identiﬁed in this study.
4. Conclusion and future prospects
Random mutagenesis is very slow and tedious for industrial
fermentation researchers and might cause unintended changes to
the entire system, but targeted approaches which do not have such
limitations can be used to further improve the current high pro-
duction strains as guided by current omics technologies and other
tools of systems biotechnology. Comparative proteomics is a
powerful tool in industrial biotechnology since the information
obtained by comparing two or more genetically different strains or
the same strain grown in different nutritional/environmental
conditions can successfully lead to design new strategies for strain
improvement even when a limited number of protein spots could
be identiﬁed. On the other hand, each x-ome alone is not sufﬁcient
since the levels of RNAs, proteins, metabolites and ﬂuxes vary
independently, but various regulatory circuits coordinate them in a
highly orchestrated fashion [83]. Especially for industrially impor-
tant secondary metabolites, an integrated combined omics for in-
spection of correlations among different x-omes is essential to
better link the components of the primary and secondary meta-
bolism, deﬁne novel targets at gene and pathway levels and design
strategies for metabolic engineering of organisms for increased
secondary metabolite titers [84]. With some potentially crucial
changes in the levels of certain proteins of primary and secondary
metabolism, the present work shed light at some degree on
proteome-wide changes that could contribute to increased pro-
duction of CA in industrial producer developed by succesive
mutagenesis programs. Other mechanisms of CA overproduction
could be speciﬁcally induced when the mutant is grown in a
complex industrial culture medium rather than in deﬁned SA. Our
comparative proteomic analyses by LC-MS/MS of industrial cultures
are underway with the hope of providing more alternative targets
to design novel overproducers.
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